These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8696077

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Enhanced anti-cancer activities of some derivatives of titanocene dichloride.
    Boyles JR, Bair MC, Campling BG, Jain N.
    J Inorg Biochem; 2001 Mar; 84(1-2):159-62. PubMed ID: 11330477
    [Abstract] [Full Text] [Related]

  • 24. Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs.
    Gómez-Ruiz S, Kaluderović GN, Prashar S, Polo-Cerón D, Fajardo M, Zizak Z, Sabo TJ, Juranić ZD.
    J Inorg Biochem; 2008 Aug; 102(8):1558-70. PubMed ID: 18353439
    [Abstract] [Full Text] [Related]

  • 25. Antitumor effectiveness and mechanism of action of Ru(II)/amino acid/diphosphine complexes in the peritoneal carcinomatosis progression.
    Mello-Andrade F, da Costa WL, Pires WC, Pereira FC, Cardoso CG, Lino-Junior RS, Irusta VRC, Carneiro CC, de Melo-Reis PR, Castro CH, Almeida MAP, Batista AA, Silveira-Lacerda EP.
    Tumour Biol; 2017 Oct; 39(10):1010428317695933. PubMed ID: 29019283
    [Abstract] [Full Text] [Related]

  • 26. Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas.
    Köpf-Maier P.
    J Cancer Res Clin Oncol; 1987 Oct; 113(4):342-8. PubMed ID: 3036884
    [Abstract] [Full Text] [Related]

  • 27. New titanocene derivatives with high antiproliferative activity against breast cancer cells.
    Saturnino C, Sirignano E, Botta A, Sinicropi MS, Caruso A, Pisano A, Lappano R, Maggiolini M, Longo P.
    Bioorg Med Chem Lett; 2014 Jan 01; 24(1):136-40. PubMed ID: 24332626
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antitumor activity of amino acid derivatives in the primary screening.
    Fukushima K, Toyoshima S.
    Gan; 1975 Feb 01; 66(1):29-36. PubMed ID: 168114
    [Abstract] [Full Text] [Related]

  • 31. Intracellular localization of titanium within xenografted sensitive human tumors after treatment with the antitumor agent titanocene dichloride.
    Köpf-Maier P.
    J Struct Biol; 1990 Feb 01; 105(1-3):35-45. PubMed ID: 2100149
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of alanine, glycine, phenylalanine, and tryptophan mustards on Ehrlich ascites carcinoma and Ridgway osteogenic sarcoma.
    Schmid FA, Stern BR, Schmid MM, Tarnowski GS.
    Cancer Chemother Rep; 1965 Dec 01; 49():1-7. PubMed ID: 5216232
    [No Abstract] [Full Text] [Related]

  • 36. A controlled release system of titanocene dichloride by electrospun fiber and its antitumor activity in vitro.
    Chen P, Wu QS, Ding YP, Chu M, Huang ZM, Hu W.
    Eur J Pharm Biopharm; 2010 Nov 01; 76(3):413-20. PubMed ID: 20854905
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
    Ghosh P, Bag SP, Sur B, Sur P.
    Neoplasma; 1998 Nov 01; 45(2):68-72. PubMed ID: 9687884
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.